Scientific Sessions 2024  /  Obesity and HFpEF: From Mechanisms to Management  /  The Intertwined Epidemics of Obesity and HFpEF: Implications for the Future of HF
Logo

American Heart Association

  106
  0

Final ID:

The Intertwined Epidemics of Obesity and HFpEF: Implications for the Future of HF

  • Pandey, Ambarish  ( UT Southwestern , Dallas , Texas , United States )
  • Tsao, Connie  ( BETH ISRAEL DEACONESS MEDICAL CTR , Boston , Massachusetts , United States )
    • Author Disclosures:
    Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Semler:Active (exists now) ; Consultant:Science37:Active (exists now) ; Research Funding (PI or named investigator):SCPharma:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:Axon:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) | Connie Tsao: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Obesity and HFpEF: From Mechanisms to Management

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Are incretin analogues the next STEP for HFpEF management in obesity?

Kosiborod Mikhail, Butler Javed

Exercise training for HFpEF in obesity: approach and clinical impact

Levine Benjamin, Kitzman Dalane, Laddu Deepika

More abstracts from these authors:
Neo’s Quest: Leveraging informatics to achieve GDMT for heart failure

Pandey Ambarish, Desai Akshay

Decoding a Silent Threat: Uncovering Aldosterone's Impact on Hypertension and Cardiovascular Morbidity

Pandey Ambarish

You have to be authorized to contact abstract author. Please, Login
Not Available